Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Amryt completes placing

    Amryt Pharma plc (LSE:AMYT; ISE:AYP), Dublin, Ireland Business: Dermatology Date completed: 2016-04-19 Type: Placing Raised: L10 million ($14.2 million) Shares: 41.7 million Price: 24p Shares after offering: 208.3 …

    Published on 4/25/2016
  • Cellectar Biosciences completes follow-on

    Cellectar Biosciences Inc. (NASDAQ:CLRB), Madison, Wis. Business: Cancer, Infectious Date completed: 2016-04-15 Type: Follow-on Raised: $8 million Shares: 1.9 million Price: $2.13 Shares after offering: 2.2 million …

    Published on 4/25/2016
  • DalCor completes venture financing

    DalCor Pharma U.K. Ltd., London, U.K. Business: Cardiovascular Date completed: 2016-04-19 Type: Venture financing Raised: $100 million Investors: Sanderling; Caisse de Depot et Placement du Quebec; Fonds de solidarite …

    Published on 4/25/2016
  • Enterome Bioscience completes venture financing

    Enterome Bioscience S.A., Paris, France Business: Autoimmune, Gastrointestinal, Diagnostic Date completed: 2016-04-20 Type: Venture financing Raised: EUR14.5 million ($16.4 million) Investors: Seventure Partners; …

    Published on 4/25/2016
  • G-Therapeutics completes venture financing

    G-Therapeutics B.V., Eindhoven, the Netherlands Business: Neurology Date completed: 2016-04-19 Type: Venture financing Raised: EUR26 million ($29.4 million) Investors: LSP; INKEF Capital; Gimv N.V.; Wellington Partners …

    Published on 4/25/2016
  • GeNeuro completes IPO

    GeNeuro S.A. (Euronext:GNRO), Geneva, Switzerland Business: Antibodies, Autoimmune, Neurology Date completed: 2016-04-14 Type: IPO Raised: EUR33 million ($37.3 million) Shares: 2.5 million Price: EUR13 Shares after …

    Published on 4/25/2016
  • Helix completes private placement of units

    Helix BioPharma Corp. (TSX:HBP), Aurora, Ontario Business: Cancer, Drug delivery, Proteomics Date completed: 2016-04-15 Type: Private placement of units Raised: C$4.7 million ($3.6 million) Price: C$1.50 (unit) Shares …

    Published on 4/25/2016
  • Hua Medicine completes venture financing

    Hua Medicine Ltd., Shanghai, China Business: Endocrine/Metabolic Date completed: 2016-04-22 Type: Venture financing Raised: $50 million Investors: Harvest Investments; Frontline BioVentures; Arch Venture Partners; Eight…

    Published on 4/25/2016
  • PeptiMimesis completes venture financing

    PeptiMimesis, Illkirch, France Business: Cancer, Autoimmune Date completed: 2016-04-20 Type: Venture financing Raised: EUR500,000 ($565,100) Investor: Cap InnovEst Note: PeptiMimesis raised EUR500,000 ($565,100) in a …

    Published on 4/25/2016
  • Proteus Digital Health completes venture financing

    Proteus Digital Health Inc., Redwood City, Calif. Business: Diagnostic Date completed: 2016-04-15 Type: Venture financing Raised: $50 million Note: The offering is a series H round.

    Published on 4/25/2016
  • Second Genome completes venture financing

    Second Genome Inc., South San Francisco, Calif. Business: Infectious, Autoimmune, Endocrine/Metabolic Date completed: 2016-04-20 Type: Venture financing Raised: $42.6 million Investors: Pfizer Venture Investments; Roche…

    Published on 4/25/2016
  • Advanced Proteome Therapeutics proposes private placement of units

    Advanced Proteome Therapeutics Corp. (TSX-V:APC; FSE:0E8), Boston, Mass. Business: Drug delivery Date announced: 2016-04-18 Type: Private placement of units To be raised: Up to C$300,000 ($231,930) Units: 6 million …

    Published on 4/25/2016
  • Gemphire proposes IPO

    Gemphire Therapeutics Inc., Northville, Mich. Business: Cardiovascular, Endocrine/Metabolic Date announced: 2016-04-18 Type: IPO To be raised: Up to $60 million Shares: TBD Price: TBD Underwriters: Jefferies; Cowen; …

    Published on 4/25/2016
  • Hemostemix proposes private placement of units

    Hemostemix Inc. (TSX-V:HEM; OTCQX:HMTXF), Calgary, Alberta Business: Cardiovascular Date announced: 2016-04-20 Type: Private placement of units To be raised: Up to C$5 million ($3.9 million) Units: 12.5 million Price: C…

    Published on 4/25/2016
  • Oncimmune proposes IPO

    Oncimmune Holdings plc, Nottingham, U.K. Business: Diagnostic Date announced: 2016-04-18 Type: IPO To be raised: About L11 million ($15.6 million) Shares: TBD Price: TBD Note: Oncimmune is seeking to list its shares on …

    Published on 4/25/2016
  • PhaseRx proposes IPO

    PhaseRx Inc., Seattle, Wash. Business: Endocrine/Metabolic Date announced: 2016-04-18 Type: IPO To be raised: Up to $25.3 million Shares: TBD Price: TBD Underwriter: Ladenburg Thalmann Note: PhaseRx is seeking to list …

    Published on 4/25/2016
  • BioCardia withdraws IPO

    BioCardia Inc., San Carlos, Calif. Business: Cardiovascular, Gene/Cell therapy Date announced: 2016-04-15 Type: IPO Underwriters: Cantor Fitzgerald; Roth Capital Partners; Maxim Group Note: BioCardia withdrew its IPO on…

    Published on 4/25/2016
  • Amyris completes private placement

    Amyris Inc. (NASDAQ:AMRS), Emeryville, Calif. Business: Biomanufacturing, Supply/Service Date completed: 2016-04-11 Type: Private placement Raised: $5 million Shares: 4.4 million Price: $1.14 Shares after offering: 211.…

    Published on 4/18/2016
  • Bavarian Nordic completes private placement

    Bavarian Nordic A/S (CSE:BAVA), Kvistgaard, Denmark Business: Infectious, Cancer Date completed: 2016-04-14 Type: Private placement Raised: DKK664.8 million ($101.6 million) Shares: 2.8 million Price: DKK240 Shares …

    Published on 4/18/2016
  • CareDx completes private placement of units

    CareDx Inc. (NASDAQ:CDNA), Brisbane, Calif. Business: Diagnostic Date completed: 2016-04-14 Type: Private placement of units Raised: $14.2 million Units: 592,000 Price: $23.94 (unit) Shares after offering: 12.6 million …

    Published on 4/18/2016
  • Fennec Pharmaceuticals completes private placement

    Fennec Pharmaceuticals Inc. (TSX:FRX), Research Triangle Park, N.C. Business: Cancer, Other Date completed: 2016-04-08 Type: Private placement Raised: $2.1 million Shares: 1.1 million Price: $1.90 Shares after offering:…

    Published on 4/18/2016
  • Imara completes venture financing

    Imara Inc., Cambridge, Mass. Business: Hematology Date completed: 2016-04-14 Type: Venture financing Raised: $31 million Investors: New Enterprise Associates; Pfizer Venture Investments; Lundbeckfond Ventures; Bay City …

    Published on 4/18/2016
  • Kala Pharmaceuticals completes venture financing

    Kala Pharmaceuticals Inc., Waltham, Mass. Business: Ophthalmic, Drug delivery Date completed: 2016-04-13 Type: Venture financing Raised: $68 million Investors: Longitude Capital Management; OrbiMed Advisors; Vivo …

    Published on 4/18/2016
  • Organogenesis completes venture financing

    Organogenesis Inc., Canton, Mass. Business: Dermatology Date completed: 2016-04-14 Type: Venture financing Raised: $30 million Investor: Existing investors

    Published on 4/18/2016
  • Portage Biotech completes private placement

    Portage Biotech Inc. (OTCBB:PTGEF; CNSX:PBT.U), Toronto, Ontario Business: Drug delivery, Ophthalmic Date completed: 2016-04-07 Type: Private placement Raised: $1 million Shares: 6.7 million Price: $0.15 Shares after …

    Published on 4/18/2016

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993